Tadashi Terui (T Terui)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 23

Top Topics

Top Venues

The Journal of dermatology

American journal of clinical dermatology

Dermatology and therapy

Clinical and experimental dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Yukari Okubo, Satomi Kobayashi, Masamoto Murakami, Shigetoshi Sano, Natsuko Kikuta, Yoshiumi Ouchi, Tadashi Terui
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial. American journal of clinical dermatology 25 (5) (2024)
Yukari Okubo, Satomi Kobayashi, Masamoto Murakami, Shigetoshi Sano, Natsuko Kikuta, Yoshiumi Ouchi, Tadashi Terui
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial. American journal of clinical dermatology 25 (5) (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Yukari Okubo, Satomi Kobayashi, Masamoto Murakami, Shigetoshi Sano, Natsuko Kikuta, Yoshiumi Ouchi, Tadashi Terui
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial. American journal of clinical dermatology (2024)
Yukari Okubo, Satomi Kobayashi, Masamoto Murakami, Shigetoshi Sano, Natsuko Kikuta, Yoshiumi Ouchi, Tadashi Terui
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial. American journal of clinical dermatology 25 (5) (2024)
Tadashi Terui, Yukari Okubo, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Natsuka Uehara, Takahiro Handa, Masayuki Tanaka, Wendy Zhang, Maria Paris, Masamoto Murakami
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study. American journal of clinical dermatology (2023)
A David Burden, Robert Bissonnette, Alexander A Navarini, Masamoto Murakami, Akimichi Morita, Thomas Haeufel, Binqi Ye, Frank Baehner, Tadashi Terui
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study. Dermatology and therapy (2023)
Keisuke Shimizu, Hideki Fujita, Daisuke Fujisawa, Koremasa Hayama, Satomi Aoki, Akiharu Kubo, Tadashi Terui
Case of type 1 segmental Darier's disease with a novel mosaic mutation in the ATP2A2 gene. The Journal of dermatology (2023)
Tadashi Terui, Yukari Okubo, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Natsuka Uehara, Takahiro Handa, Masayuki Tanaka, Wendy Zhang, Maria Paris, Masamoto Murakami
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study. American journal of clinical dermatology (2023)
Koremasa Hayama, Hideki Fujita, Tadashi Terui
Current trend in the treatment of generalized pustular psoriasis in Japan: Results from a questionnaire-based epidemiological study. The Journal of dermatology 49 (12) (2022)
Maho Nishimura-Tagui, Koremasa Hayama, Hideki Fujita, Yuji Miyamoto, Norihisa Ishii, Tadashi Terui
Disseminated Mycobacterium massiliense skin infection in an immunocompromised patient requiring long-term treatment. The Journal of dermatology 48 (4) (2021)
Natsumi Ikumi, Tadashi Terui, Hideki Fujita
Peripheral arthritis presenting pencil-in-cup deformity in a patient with palmoplantar pustulosis. The Journal of dermatology 48 (12) (2021)
Yusuke Niwa, Koremasa Hayama, Satoshi Izaki, Hiroshi Koga, Norito Ishii, Tadashi Terui, Hideki Fujita
Mucosa-predominant pemphigus vulgaris with anti-desmocollin 2 and 3 antibody positivity and ocular symptoms. Clinical and experimental dermatology 46 (8) (2021)
Natsumi Ikumi, Koremasa Hayama, Tadashi Terui, Noboru Kitamura, Masami Takei, Hideki Fujita
Retrospective study of the differences in the management for pustulotic arthro-osteitis in patients with palmoplantar pustulosis between dermatologists and rheumatologists. The Journal of dermatology 48 (11) (2021)
Toshiyuki Yamamoto, Tomoko Hiraiwa, Rie Tobita, Hirofumi Hirano, Kana Masuda-Kuroki, Madoka Ishii, Masamoto Murakami, Tadashi Terui, Yukari Okubo
Characteristics of Japanese patients with pustulotic arthro-osteitis associated with palmoplantar pustulosis: a multicenter study. International journal of dermatology 59 (4) (2020)
Natsumi Ikumi, Hideki Fujita, Tadashi Terui
Guselkumab improves joint pain in patients with pustulotic arthro-osteitis: A retrospective pilot study. The Journal of dermatology 48 (2) (2020)
Koremasa Hayama, Hideki Fujita, Keiji Iwatsuki, Tadashi Terui
Improved quality of life of patients with generalized pustular psoriasis in Japan: A cross-sectional survey. The Journal of dermatology 48 (2) (2020)
Takahiro Endo, Shota Toyoshima, Koremasa Hayama, Maho Nishimura-Tagui, Yusuke Niwa, Mana Ito, Tadashi Terui, Yoshimichi Okayama
Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria. Asia Pacific allergy 10 (2) (2020)
Hideki Fujita, Mamitaro Ohtsuki, Akimichi Morita, Ryuji Nagao, Noriko Seko, Kazuko Matsumoto, Yumiko Tani, Tadashi Terui
Safety and effectiveness of secukinumab in psoriasis vulgaris and psoriatic arthritis: Real-world evidence in Japan. The Journal of dermatology 48 (2) (2020)